Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
5,013 Dovepress* 4,477 273+ 634 4,750
PubMed Central* 0 263 96 263
Totals 4,477 536 730 5,013
*Since 4 May 2018
+Since July 2016

View citations on PubMed Central and Google Scholar